These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2947417)

  • 1. Serum amyloid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome.
    Elovaara I; Maury CP; Palo J
    Acta Neurol Scand; 1986 Sep; 74(3):245-50. PubMed ID: 2947417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteins in serum and cerebrospinal fluid in demented patients with Down's syndrome.
    Elovaara I
    Acta Neurol Scand; 1984 May; 69(5):302-5. PubMed ID: 6235703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.
    Mann DM; Jones D; Prinja D; Purkiss MS
    Acta Neuropathol; 1990; 80(3):318-27. PubMed ID: 1698007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome.
    Naudé PJ; Dekker AD; Coppus AM; Vermeiren Y; Eisel UL; van Duijn CM; Van Dam D; De Deyn PP
    J Alzheimers Dis; 2015; 45(3):733-43. PubMed ID: 25613101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human amyloid-related protein SAA as a polymorphic protein: association with albumin and prealbumin in serum.
    Marhaug G; Husby G
    Clin Exp Immunol; 1981 Jul; 45(1):97-106. PubMed ID: 7307348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with Down syndrome.
    Dekker AD; Coppus AM; Vermeiren Y; Aerts T; van Duijn CM; Kremer BP; Naudé PJ; Van Dam D; De Deyn PP
    J Alzheimers Dis; 2015; 43(3):871-91. PubMed ID: 25125467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging, Down's syndrome and Alzheimer's disease: research and clinical implications.
    Prasher V; Cumella S; Natarajan K; Rolfe E; Shah S; Haque MS
    J Intellect Disabil Res; 2003 Feb; 47(Pt 2):90-100. PubMed ID: 12542574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological alpha 1-antichymotrypsin in Down's syndrome and Alzheimer's disease.
    Brugge K; Katzman R; Hill LR; Hansen LA; Saitoh T
    Ann Neurol; 1992 Aug; 32(2):193-7. PubMed ID: 1387300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing.
    van Gool WA; Evenhuis HM; van Duijn CM
    Ann Neurol; 1995 Aug; 38(2):225-30. PubMed ID: 7654070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the APOE alleles impact in Down's syndrome.
    Lambert JC; Pérez-Tur J; Dupire MJ; Delacourte A; Frigard B; Chartier-Harlin MC
    Neurosci Lett; 1996 Dec; 220(1):57-60. PubMed ID: 8977148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinsonian features in advanced Down's syndrome.
    Vieregge P; Ziemens G; Piosinski A; Freudenberg M; Kömpf D
    J Neural Transm Suppl; 1991; 33():119-24. PubMed ID: 1836496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome.
    Martins RN; Clarnette R; Fisher C; Broe GA; Brooks WS; Montgomery P; Gandy SE
    Neuroreport; 1995 Jul; 6(11):1513-6. PubMed ID: 7579137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease.
    Bodhireddy S; Dickson DW; Mattiace L; Weidenheim KM
    Neurology; 1994 Jan; 44(1):159-61. PubMed ID: 8290054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing dementia in adults with Down's syndrome.
    Prasher VP; Sachdeva N; Tarrant N
    Neurodegener Dis Manag; 2015; 5(3):249-56. PubMed ID: 26107323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.
    Portelius E; Soininen H; Andreasson U; Zetterberg H; Persson R; Karlsson G; Blennow K; Herukka SK; Mattsson N
    Neurodegener Dis; 2014; 14(2):98-106. PubMed ID: 24992945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.
    Glenner GG; Wong CW
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1131-5. PubMed ID: 6236805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer's disease.
    Riisøen H
    Acta Neurol Scand; 1988 Dec; 78(6):455-9. PubMed ID: 3223231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and Down's syndrome: treating two paths to dementia.
    Weksler ME; Szabo P; Relkin NR; Reidenberg MM; Weksler BB; Coppus AM
    Autoimmun Rev; 2013 Apr; 12(6):670-3. PubMed ID: 23201920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A German version of the Cambridge examination for mental disorders of older people with Down's syndrome and others with intellectual disabilities : A diagnostic procedure for detecting dementia in people with Down's syndrome].
    Nübling G; Loosli SV; Wlasich E; Prix C; Schönecker S; Freudelsperger L; Smrzka N; Strydom AM; Zaman SH; Benejam B; Missios J; Meister R; Danek A; Levin J
    Z Gerontol Geriatr; 2020 Oct; 53(6):546-551. PubMed ID: 31399752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.